These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36505804)

  • 21. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
    Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
    EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.
    Kantarjian H; O'brien S; Cortes J; Giles F; Faderl S; Jabbour E; Garcia-Manero G; Wierda W; Pierce S; Shan J; Estey E
    Cancer; 2006 Mar; 106(5):1090-8. PubMed ID: 16435386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
    Boddu PC; Kadia TM; Garcia-Manero G; Cortes J; Alfayez M; Borthakur G; Konopleva M; Jabbour EJ; Daver NG; DiNardo CD; Naqvi K; Yilmaz M; Short NJ; Pierce S; Kantarjian HM; Ravandi F
    Cancer; 2019 Apr; 125(7):1091-1100. PubMed ID: 30521114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
    Li Z; Herold T; He C; Valk PJ; Chen P; Jurinovic V; Mansmann U; Radmacher MD; Maharry KS; Sun M; Yang X; Huang H; Jiang X; Sauerland MC; Büchner T; Hiddemann W; Elkahloun A; Neilly MB; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Döhner K; Bullinger L; Liu PP; Delwel R; Marcucci G; Lowenberg B; Bloomfield CD; Rowley JD; Bohlander SK; Chen J
    J Clin Oncol; 2013 Mar; 31(9):1172-81. PubMed ID: 23382473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
    Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Classification and Prognosis in Acute Myeloid Leukemia.
    Papaemmanuil E; Gerstung M; Bullinger L; Gaidzik VI; Paschka P; Roberts ND; Potter NE; Heuser M; Thol F; Bolli N; Gundem G; Van Loo P; Martincorena I; Ganly P; Mudie L; McLaren S; O'Meara S; Raine K; Jones DR; Teague JW; Butler AP; Greaves MF; Ganser A; Döhner K; Schlenk RF; Döhner H; Campbell PJ
    N Engl J Med; 2016 Jun; 374(23):2209-2221. PubMed ID: 27276561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.
    Pogosova-Agadjanyan EL; Moseley A; Othus M; Appelbaum FR; Chauncey TR; Chen IL; Erba HP; Godwin JE; Jenkins IC; Fang M; Huynh M; Kopecky KJ; List AF; Naru J; Radich JP; Stevens E; Willborg BE; Willman CL; Wood BL; Zhang Q; Meshinchi S; Stirewalt DL
    Biomark Res; 2020; 8():29. PubMed ID: 32817791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
    Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.
    Harada Y; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kobayashi S; Kitamura K; Sakaida E; Onizuka M; Takeshita A; Ishida F; Suzushima H; Ishizawa K; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H;
    Leuk Res; 2018 Mar; 66():20-27. PubMed ID: 29360622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
    Herold T; Rothenberg-Thurley M; Grunwald VV; Janke H; Goerlich D; Sauerland MC; Konstandin NP; Dufour A; Schneider S; Neusser M; Ksienzyk B; Greif PA; Subklewe M; Faldum A; Bohlander SK; Braess J; Wörmann B; Krug U; Berdel WE; Hiddemann W; Spiekermann K; Metzeler KH
    Leukemia; 2020 Dec; 34(12):3161-3172. PubMed ID: 32231256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature.
    Nehme A; Dakik H; Picou F; Cheok M; Preudhomme C; Dombret H; Lambert J; Gyan E; Pigneux A; Récher C; Béné MC; Gouilleux F; Zibara K; Herault O; Mazurier F
    Blood Adv; 2020 Oct; 4(20):5322-5335. PubMed ID: 33108456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy.
    Ni J; Hong J; Long Z; Li Q; Xia R; Zeng Q
    Int J Lab Hematol; 2020 Dec; 42(6):849-857. PubMed ID: 32730663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.
    Simoes C; Paiva B; Martínez-Cuadrón D; Bergua JM; Vives S; Algarra L; Tormo M; Martinez P; Serrano J; Herrera P; Ramos F; Salamero O; Lavilla E; Gil C; Lopez JL; Vidriales MB; Labrador J; Falantes JF; Sayas MJ; Ayala R; Martinez-Lopez J; Villar S; Calasanz MJ; Prosper F; San-Miguel JF; Sanz MÁ; Montesinos P
    Blood Adv; 2021 Feb; 5(3):760-770. PubMed ID: 33560390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
    Fujiwara Y; Yamaguchi H; Yui S; Tokura T; Inai K; Onai D; Omori I; Marumo A; Yamanaka S; Sakaguchi M; Terada K; Nakagome S; Arai K; Kitano T; Okabe M; Okamoto M; Tamai H; Nakayama K; Tajika K; Wakita S; Inokuchi K
    Int J Lab Hematol; 2019 Aug; 41(4):461-471. PubMed ID: 30970181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of newly diagnosed acute myeloid leukemia with myelodysplasia related changes and elderly acute myeloid leukemia following decitabine therapy in combination with priming regimen.
    Lai B; Mu Q; Zhang Y; Chen Y; Yan X; Ouyang G
    Hematology; 2021 Dec; 26(1):751-757. PubMed ID: 34555298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Ferraro F; Miller CA; Christensen KA; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Kohlschmidt J; Eisfeld AK; Bloomfield CD; Ramakrishnan SM; Day RB; Wartman LD; Uy GL; Welch JS; Christopher MJ; Heath SE; Baty JD; Schuelke MJ; Payton JE; Spencer DH; Rettig MP; Link DC; Walter MJ; Westervelt P; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia.
    Zhang N; Liu X; Wu J; Li X; Wang Q; Chen G; Ma L; Wu S; Zhou F
    Ther Adv Hematol; 2022; 13():20406207221132346. PubMed ID: 36324489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Hansen DK; Kim J; Thompson Z; Hussaini M; Nishihori T; Ahmad A; Elmariah H; Faramand R; Mishra A; Davila ML; Khimani F; Lazaryan A; Sallman D; Liu H; Perez LE; Fernandez H; Nieder ML; Lancet JE; Pidala JA; Anasetti C; Bejanyan N
    Transplant Cell Ther; 2021 Mar; 27(3):256.e1-256.e7. PubMed ID: 33781526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.